Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer

Stopped Sponsor decision.

Conditions

• Metastatic Breast Cancer

Interventions

• DEVICE: Epicutaneous cryoimmunotherapy
• DRUG: Topical imiquimod
• DRUG: Pembrolizumab
• OTHER: Dermatologic Quality of Life Index
• OTHER: Functional Assessment of Cancer Therapy
• DRUG: Intra-lesional GM-CSF
• DEVICE: Cry-AC
• PROCEDURE: Cutaneous tumor biopsy
• PROCEDURE: Peripheral blood draw for research

Sponsor

Washington University School of Medicine

Collaborators

• [object Object]